| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Discordia Robert Paul is a Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc.. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $344K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2020 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Chief Operating Officer | Buy | 2,840 | $3.54 | $10,053.60 | +8.7% | |
| Nov 11, 2019 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Chief Operating Officer | Buy | 2,500 | $4.62 | $11,558.50 | +8.3% | |
| Aug 12, 2019 | CRBP Corbus Pharmaceuticals Holdings, Inc. | Chief Operating Officer | Buy | 15,000 | $5.86 | $87,894.00 | +99.0% |